|
|
Article: University of Florida Shands Cancer Center Selects OnCore(r) to Support its Collaborative Research Goals.
- Article from:
- PRWeb
- Article date:
- July 15, 2009
CopyrightCOPYRIGHT 2009 COMTEX News Network, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Madison, WI, Jul 15, 2009 (PRWeb.com via COMTEX) -- An institutional goal to develop collaborative partnerships with other research organizations was a key factor in the recent decision by the University of Florida Shands Cancer Center (UFSCC) to select OnCore(r) products in support of their clinical and translational research informatics (http://www.percipenz.com/clinical.php) needs. With the signing of the contract, the UFSCC has become the 25th cancer center to adopt the OnCore platform.
"We began looking for a new clinical trials management system primarily because of our collaborative agreement with the Moffitt Cancer Center," said Giselle Moore-Higgs, ...
Related newspaper, magazine, and journal articles:
|
|
Article: Research from University of Florida, Shands Cancer ...
Gene Therapy Weekly;
February 5, 2009 ;
700+ words
... ... N. Su and colleagues, University of Florida, Shands Cancer Center (see also Gene Therapy). The researchers concluded ... Dept. of Biochemistry and Molecular Biology, Shands Cancer Center and Center for Nutritional Sciences, Gainesville ...
|
|